Zomedica Corp (AMEX:ZOM) has a beta value of 0.99 and has seen 3.05 million shares traded in the recent trading session. The company, currently valued at $139.15M, closed the recent trade at $0.14 per share which meant it 1.79% during that session. The ZOM stock price is -78.57% off its 52-week high price of $0.25 and 14.29% above the 52-week low of $0.12. The 3-month trading volume is 4.76 million shares.

Zomedica Corp (AMEX:ZOM) trade information

Sporting 1.79% in the green today, the stock has traded in the green over the last five days, when the ZOM stock price touched $0.14 or saw a rise of 1.96%. Year-to-date, Zomedica Corp shares have moved -29.07%, while the 5-day performance has seen it change 8.15%. Over the past 30 days, the shares of Zomedica Corp (AMEX:ZOM) have changed 1.43%.

Zomedica Corp (ZOM) estimates and forecasts

The company’s shares have lost -8.45% over the past 6 months, compared to 14.40% for the industry. Revenue growth from the last financial year stood is estimated to be 35.40%.

1 analysts offering their estimates for the company have set an average revenue estimate of $8.18 million for the current quarter. 1 have an estimated revenue figure of $8.35 million for the next quarter concluding in Jun 2024. Year-ago sales stood $5.48 million and $6.02 million respectively for this quarter and the next, and analysts expect sales will grow by 49.20% for the current quarter and 38.70% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 27.70% over the past 5 years.

ZOM Dividends

Zomedica Corp is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.